Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland.
Welch Medical Library, The Johns Hopkins University, Baltimore, Maryland.
JAMA Netw Open. 2020 May 1;3(5):e205894. doi: 10.1001/jamanetworkopen.2020.5894.
Language and indexing biases may exist among Chinese-sponsored randomized clinical trials (CS-RCTs). Such biases may threaten the validity of systematic reviews.
To evaluate the existence of language and indexing biases among CS-RCTs on drug interventions.
DESIGN, SETTING, AND PARTICIPANTS: In this retrospective cohort study, eligible CS-RCTs were retrieved from trial registries, and bibliographic databases were searched to determine their publication status. Eligible CS-RCTs were for drug interventions conducted from January 1, 2008, to December 31, 2014. The search and analysis were conducted from March 1 to August 31, 2019. Primary trial registries were recognized by the World Health Organization and the Drug Clinical Trial Registry Platform sponsored by the China Food and Drug Administration.
Individual CS-RCTs with positive vs negative results (positive vs negative CS-RCTs).
For assessing language bias, the main outcome was the language of the journal in which CS-RCTs were published (English vs Chinese). For indexing bias, the main outcome was the language of the bibliographic database where the CS-RCTs were indexed (English vs Chinese).
The search identified 891 eligible CS-RCTs. Four hundred seventy CS-RCTs were published by August 31, 2019, of which 368 (78.3%) were published in English. Among CS-RCTs registered in the Chinese Clinical Trial Registry (ChiCTR), positive CS-RCTs were 3.92 (95% CI, 2.20-7.00) times more likely to be published in English than negative CS-RCTs; among CS-RCTs in English-language registries, positive CS-RCTs were 3.22 (95% CI, 1.34-7.78) times more likely to be published in English than negative CS-RCTs. These findings suggest the existence of language bias. Among CS-RCTs registered in ChiCTR, positive CS-RCTs were 2.89 (95% CI, 1.55-5.40) times more likely to be indexed in English bibliographic databases than negative CS-RCTs; among CS-RCTs in English-language registries, positive CS-RCTs were 2.19 (95% CI, 0.82-5.82) times more likely to be indexed in English bibliographic databases than negative CS-RCTs. These findings support the existence of indexing bias.
This study suggests the existence of language and indexing biases among registered CS-RCTs on drug interventions. These biases may distort evidence synthesis toward more positive results of drug interventions.
中文发起的随机临床试验(CS-RCTs)中可能存在语言和索引偏差。这些偏差可能会威胁到系统评价的有效性。
评估药物干预的 CS-RCT 中是否存在语言和索引偏差。
设计、设置和参与者:在这项回顾性队列研究中,从试验注册处检索符合条件的 CS-RCT,并在文献数据库中进行搜索以确定其发表状态。符合条件的 CS-RCT 为 2008 年 1 月 1 日至 2014 年 12 月 31 日期间进行的药物干预。搜索和分析于 2019 年 3 月 1 日至 8 月 31 日进行。主要试验注册处由世界卫生组织和中国食品药品监督管理局赞助的药物临床试验登记平台认可。
阳性结果与阴性结果的个体 CS-RCT(阳性 CS-RCT 与阴性 CS-RCT)。
为评估语言偏倚,主要结局是 CS-RCT 发表的期刊的语言(英语与中文)。对于索引偏差,主要结局是 CS-RCT 索引的文献数据库的语言(英语与中文)。
搜索共确定了 891 项符合条件的 CS-RCT。截至 2019 年 8 月 31 日,有 470 项 CS-RCT 发表,其中 368 项(78.3%)以英文发表。在中国临床试验注册中心(ChiCTR)注册的 CS-RCT 中,阳性 CS-RCT 发表为英文的可能性是阴性 CS-RCT 的 3.92 倍(95% CI,2.20-7.00);在英文注册处的 CS-RCT 中,阳性 CS-RCT 发表为英文的可能性是阴性 CS-RCT 的 3.22 倍(95% CI,1.34-7.78)。这些发现表明存在语言偏倚。在中国临床试验注册中心注册的 CS-RCT 中,阳性 CS-RCT 被索引到英文文献数据库的可能性是阴性 CS-RCT 的 2.89 倍(95% CI,1.55-5.40);在英文注册处的 CS-RCT 中,阳性 CS-RCT 被索引到英文文献数据库的可能性是阴性 CS-RCT 的 2.19 倍(95% CI,0.82-5.82)。这些发现支持索引偏差的存在。
这项研究表明,药物干预的注册 CS-RCT 中存在语言和索引偏差。这些偏差可能会扭曲药物干预的证据综合,使其更倾向于积极的结果。